<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05008770</url>
  </required_header>
  <id_info>
    <org_study_id>s65127</org_study_id>
    <secondary_id>B32220221000449</secondary_id>
    <nct_id>NCT05008770</nct_id>
  </id_info>
  <brief_title>Trial in Elderly With Musculoskeletal Problems Due to Underlying Sarcopenia - Faeces to Unravel Gut and Inflammation Translationally</brief_title>
  <acronym>TEMPUS-FUGIT</acronym>
  <official_title>Trial in Elderly With Musculoskeletal Problems Due to Underlying Sarcopenia - Faeces to Unravel Gut and Inflammation Translationally</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Research Foundation Flanders</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall aim of the TEMPUS-FUGIT study is to assess gut microbiota composition in older&#xD;
      persons without sarcopenia and to determine the relationship with and between intestinal and&#xD;
      systemic inflammation and with sarcopenia-defining parameters (muscle mass, muscle strength&#xD;
      and physical performance). The gut microbiota of older persons without sarcopenia (included&#xD;
      in TEMPUS-FUGIT) will be compared with the gut microbiota of older people with sarcopenia,&#xD;
      participating in the Exercise and Nutrition for Healthy AgeiNg (ENHANce) study (NCT03649698).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2021</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Gut microbiota composition</measure>
    <time_frame>Baseline</time_frame>
    <description>Gut microbiota composition (measured through 16S ribosomal RNA (rRNA) gene sequencing).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intestinal inflammation</measure>
    <time_frame>Baseline</time_frame>
    <description>Markers of intestinal inflammation: fecal calprotectin, lactoferrin, S100A12</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systemic inflammation</measure>
    <time_frame>Baseline</time_frame>
    <description>Markers of inflammation in blood samples: C reactive protein (hs-CRP), sedimentation rate, Interleukin 6 (IL-6), IL-4, IL-13, IL-1b, Tumor necrosis factor alpha</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical performance</measure>
    <time_frame>Baseline</time_frame>
    <description>Short Physical Performance Battery (SPPB) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical performance (gait speed)</measure>
    <time_frame>Baseline</time_frame>
    <description>gait speed (expressed in m/s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength (upper limbs)</measure>
    <time_frame>Screening; baseline</time_frame>
    <description>Handgrip strength measured with Jamar dynamometer (expressed in kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength (lower limbs)</measure>
    <time_frame>Screening; baseline</time_frame>
    <description>Chair stand test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle mass (BIA)</measure>
    <time_frame>Baseline</time_frame>
    <description>Appendicular lean mass measured with a Dual-energy X-ray absorptiometry (DXA) scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle mass (DXA)</measure>
    <time_frame>Baseline</time_frame>
    <description>Appendicular lean mass measured with bioelectrical impedance analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary intake</measure>
    <time_frame>Baseline</time_frame>
    <description>Food diaries will help to evaluate dietary protein and fatty acids intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary nitrogen</measure>
    <time_frame>Baseline</time_frame>
    <description>Urinary nitrogen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status</measure>
    <time_frame>Baseline</time_frame>
    <description>Frailty scale according to Fried et al. (2001)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status (ADL)</measure>
    <time_frame>Baseline</time_frame>
    <description>Activities of daily living (Barthel index)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Balance</measure>
    <time_frame>Baseline</time_frame>
    <description>Mini-Balance Evaluation Systems Test (Mini-BESTest)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>Baseline</time_frame>
    <description>Time of physical activity throughout the day measured with MoveMonitor+</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life (SF-36)</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured trough the Short Form Health Questionnaire (SF-36) Quality of Life)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life (SarQoL)</measure>
    <time_frame>Baseline</time_frame>
    <description>SarQoL(Sarcopenia Quality of Life)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive status (MMSE)</measure>
    <time_frame>Baseline</time_frame>
    <description>Mini-Mental State Exam (MMSE)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive status (RBANS)</measure>
    <time_frame>Baseline</time_frame>
    <description>Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Older adults without sarcopenia</arm_group_label>
    <description>Healthy volunteers aged 65+ years who do not fulfill diagnostic criteria for sarcopenia, according to the revised European Working Group on Sarcopenia in Older People (EWGSOP2)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Older adults without sarcopenia</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool, blood and urine samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers (aged 65+ years) without probable, confirmed or severe sarcopenia&#xD;
        (according to the EWGSOP2), matched according to gender, age and BMI with participants of&#xD;
        ENHANce (NCT03649698)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female persons without probable, confirmed or severe sarcopenia according to&#xD;
             the European Working Group on Sarcopenia in Older People (EWGSOP2): no reduced muscle&#xD;
             strength measured by chair stand test or hand grips strength&#xD;
&#xD;
          -  65 years or older&#xD;
&#xD;
          -  Community-dwelling elderly or assisted living&#xD;
&#xD;
          -  Dutch speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Impairments/diseases that affect performance of daily activities&#xD;
&#xD;
          -  Persons who are systematically physically active (e.g. routine or organized sports&#xD;
             activities) or who followed a physical activity training program (e.g., rehabilitation&#xD;
             program) in the last 6 months (systematically = twice or more/week)&#xD;
&#xD;
          -  Diagnosis of diabetes mellitus, measured by fasting glucose ≥126 mg/dL or HbA1C ≥ 6.5%&#xD;
             at screening or in recent (maximum 3 months old) lab report&#xD;
&#xD;
          -  Use of antibiotics in the last 3 months&#xD;
&#xD;
          -  Gastrointestinal cancer (active or treated in the last 5 years)&#xD;
&#xD;
          -  No freezer at home available&#xD;
&#xD;
        After the screening visit, included persons will be invited for a test visit.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evelien Gielen, PhD MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gerontology and Geriatrics, Department of Public Health and Primary Care, KULeuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jolan Dupont, MD</last_name>
    <phone>+32 16 34 32 01</phone>
    <email>jolan.dupont@uzleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura Vercauteren, MSc</last_name>
    <phone>+32 16 34 38 67</phone>
    <email>laura.vercauteren@kuleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Vercauteren, MSc</last_name>
      <phone>+3216343867</phone>
      <email>laura.vercauteren@kuleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Jolan Dupont, MD</last_name>
      <phone>+3216343201</phone>
      <email>jolan.dupont@uzleuven.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 28, 2021</study_first_submitted>
  <study_first_submitted_qc>August 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gut microbiota</keyword>
  <keyword>gut-muscle axis</keyword>
  <keyword>healthy ageing</keyword>
  <keyword>intestinal inflammation</keyword>
  <keyword>systemic inflammation</keyword>
  <keyword>gut microbiome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

